R to @ECDC_EU: To address these concerns, we recommend:
-> enhanced surveillance
-> continued & expanded quality-assured antimicrobial susceptibility surveillance to detect & monitor resistance patterns promptly
-> regular review and updates of the treatment guidelines

https://bit.ly/4bPfPSQ

[2024-06-10 11:52 UTC]